Vitrectomy for Proliferative Diabetic Retinopathy in a Patient with Heparin-Induced Thrombocytopenia

Publisher： Karger

E-ISSN： 1663-2699|7|1|67-73

ISSN： 1663-2699

Source： Case Reports in Ophthalmology, Vol.7, Iss.1, 2016-01, pp. : 67-73

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitrectomy for Proliferative Diabetic Retinopathy and Macular Hole

By Lee Bailey L.  

Annals of Ophthalmology, Vol. 32, Iss. 2, 2000-06 ,pp. : 144-145

Humana Press, Inc

Access to resources Recommend Favorite

Vitrectomy for Proliferative Diabetic Retinopathy Associated with Klinefelter Syndrome

By  

Case Reports in Ophthalmology, Vol. 6, Iss. 3, 2015-12 ,pp. : 420-426

Karger

Access to resources Recommend Favorite

Intrasilicone Bevacizumab Injection for Iris Neovascularization after Vitrectomy for Proliferative Diabetic Retinopathy

By  

Ophthalmic Research, Vol. 49, Iss. 1, 2012-09 ,pp. : 20-24

Karger

Access to resources Recommend Favorite

Outcomes and Complications of 25-Gauge Transconjunctival Sutureless Vitrectomy for Proliferative Diabetic Retinopathy

By  

Ophthalmologica, Vol. 226, Iss. 2, 2011-05 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Bevacizumab (Avastin) as an Adjunct to Vitrectomy in the Management of Severe Proliferative Diabetic Retinopathy: A Prospective Case Series

By  

Ophthalmic Research, Vol. 45, Iss. 1, 2010-08 ,pp. : 23-30

Karger

Access to resources Recommend Favorite